ARX788 in HER2-positive Metastatic Breast Cancer Patients

Clinical trial NCT06663748 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06663748
Sponsor: Henan Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive, Metastatic Breast Cancer

Start date: 2024-11-20
Primary completion: 2025-11-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.